December 23rd, 2011 by PreparedPatient in Health Tips, Opinion
No Comments »
Talking About Side Effects With Your Health Care Team
Side effects may occur with any new treatment, including new medications, placement of a new medical device, surgery, or even physical or occupational therapy. We usually think of side effects when we begin to experience bad changes —when the treatment introduces new worrisome symptoms or problems. Most treatments have some sort of side effect associated with them, and many of us may wonder if side effects are simply the price we must pay for a necessary treatment.
But side effects shouldn’t be taken lightly, for a number of reasons. At their most extreme, side effects raise the alarm when you are having harmful and even potentially fatal treatment reactions. Even somewhat mild side effects like a dry mouth, sleepiness, or minor muscle aches may still interfere with your daily life. Sometimes side effects bother some people so much that they skip doses or give up a treatment altogether, which can derail care and put them at risk for both short- and long-term complications.
Before treatment begins, here are a few questions you can discuss with your health care team: Read more »
*This blog post was originally published at Prepared Patient Forum: What It Takes Blog*
December 18th, 2011 by Dinah Miller, M.D. in Opinion, Research
No Comments »
For a while now we’ve been talking about issues related to psychiatry and electronic medical records. Roy is very interested in the evolution of EHR’s.
I don’t like them. I think they have too many problems still, both in terms of issues of efficiency and time, and how they divert the physician’s attention away from the patient, and they focus medical appointments on the collection of data– data that is used in a checkbox form: patient is not suicidal and I asked, whether it was clinically relevant or not– and will therefore serve as protection in a lawsuit, or demographic information used by insurers, the government, who knows.
From a privacy standpoint, I think they are appalling. If you are a patient in the hospital where I work, you get Read more »
*This blog post was originally published at Shrink Rap*
December 3rd, 2011 by PeterWehrwein in Research
1 Comment »
Some medications are well known for being risky, especially for older people. Certain antihistamines, barbiturates, muscle relaxants—take too much of them, or take them with certain other medications, and you can wind up in serious trouble (and possibly in the back of ambulance).
But researchers from the federal Centers for Disease Control and Prevention (CDC) and Emory University reported in this week’s New England Journal of Medicine that those high-risk medications are not the ones that most commonly put older Americans (ages 65 and older) in the hospital.
Warfarin is #1
Instead, they found that warfarin is the most common culprit. Warfarin (the brand-name version is called Coumadin) reduces the blood’s tendency to clot. Many older people take it to lower their risk of getting a stroke.
After warfarin, different Read more »
*This blog post was originally published at Harvard Health Blog*
November 27th, 2011 by EvanFalchukJD in Opinion
No Comments »
Guatemala is a developing country, with great natural beauty, hard-working people and many challenges. Most Americans look at places like Guatemala and see only the challenges. Some see opportunity.
I’ve just returned from Guatemala, where I met with our business partners, government officials, and others. And I can tell you a universal truth. People across the world want the best medical care they can get. They aren’t looking for the latest technologies and drugs and treatments – or, rather, they aren’t looking only for those things. No, what is most important to whoever I meet, no matter where they live, is that they are able to get the right diagnosis, and the right treatment.
It’s a harder thing to get in some places than in others. Americans don’t realize that Read more »
*This blog post was originally published at BestDoctors.com: See First Blog*
November 24th, 2011 by PJSkerrett in News
No Comments »
Last week, the FDA revoked its 2008 approval of the drug Avastin to treat breast cancer, concluding that the drug does little to help women with breast cancer while putting them at risk for potentially life-threatening side effects. Avastin will remain on the market (and so be potentially available to women with breast cancer) because it has also been approved to treat other types of cancer.
In a statement, FDA Commissioner Margaret A. Hamburg said this:
FDA recognizes how hard it is for patients and their families to cope with metastatic breast cancer and how great a need there is for more effective treatments. But patients must have confidence that the drugs they take are both safe and effective for their intended use. After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks. Nor is there evidence that use of Avastin will either help them live longer or improve their quality of life.
*This blog post was originally published at Harvard Health Blog*
